Newbridge Financial Services Group, Inc. Editas Medicine, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $617 Million
- Q3 2025
A detailed history of Newbridge Financial Services Group, Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 300 shares of EDIT stock, worth $780. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 300
-0.0%
Holding current value
$780
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding EDIT
# of Institutions
226Shares Held
46.2MCall Options Held
841KPut Options Held
304K-
Black Rock Inc. New York, NY7.78MShares$20.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.97MShares$18.1 Million0.0% of portfolio
-
Nuveen, LLC Charlotte, NC2.09MShares$5.44 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$5.3 Million0.0% of portfolio
-
State Street Corp Boston, MA1.93MShares$5.01 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $179M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...